CAS: 1036730-42-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Pidilizumab REF: TM-T81461CAS: 1036730-42-3 | 98% | A consultar | Jue 11 Jul 24 | |
Pidilizumab REF: 3D-CLA1320CAS: 1036730-42-3 | - - - | A consultar | Mar 23 Jul 24 |
Pidilizumab
CAS:1036730-42-3
Pidilizumab (CT-011), a humanized IgG1κ anti-PD-1 monoclonal antibody, serves as a DLL1 antagonist with potential …
Pureza:
98%
Ref: TM-T81461
1mg | A consultar | ||
5mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 11 de Julio de 2024
Pidilizumab
CAS:1036730-42-3
Anti-DLL1 monoclonal antibody; potential for cancer and infectious disease treatment
Ref: 3D-CLA1320
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 23 de Julio de 2024